Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben van Calster

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|April 13, 2013
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian massesAhmad Sayasneh, Jeroen Kaijser, Jessica Preisler, et al.
The Lancet. Oncology|February 14, 2012
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational studyFrédéric Amant, Kristel Van Calsteren, Michael J Halaska, et al.
The Lancet. Digital Health|December 14, 2025
Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidanceBen Van Calster, Gary S Collins, Andrew J Vickers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve AnalysisLaure Wynants, Dirk Timmerman, Jan Y Verbakel, et al.
American Journal of Obstetrics and Gynecology|July 13, 2025
External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6)Francesca Moro, Marina Momi, Ashleigh Ledger, et al.
Menopause (New York, N.Y.)|October 1, 2010
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozoleBen Van Calster, Johan Van Ginderachter, Jos Vlasselaer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 24, 2021
Evaluating cut-off levels for progesterone, β human chorionic gonadotropin and β human chorionic gonadotropin ratio to exclude pregnancy viability in women with a pregnancy of unknown location: A prospective multicenter cohort studyShabnam Bobdiwala, Christopher Kyriacou, Evangelia Christodoulou, et al.
Fertility and Sterility|October 16, 2010
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcomeKurt Barnhart, Norah M van Mello, Tom Bourne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvementPatrick Neven, Olivier Brouckaert, Vanya Van Belle, et al.
BMJ Open|August 11, 2016
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancerSudha Sundar, Caroline Rick, Francis Dowling, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|April 13, 2013
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian massesAhmad Sayasneh, Jeroen Kaijser, Jessica Preisler, et al.
The Lancet. Oncology|February 14, 2012
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational studyFrédéric Amant, Kristel Van Calsteren, Michael J Halaska, et al.
The Lancet. Digital Health|December 14, 2025
Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidanceBen Van Calster, Gary S Collins, Andrew J Vickers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve AnalysisLaure Wynants, Dirk Timmerman, Jan Y Verbakel, et al.
American Journal of Obstetrics and Gynecology|July 13, 2025
External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6)Francesca Moro, Marina Momi, Ashleigh Ledger, et al.
Menopause (New York, N.Y.)|October 1, 2010
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozoleBen Van Calster, Johan Van Ginderachter, Jos Vlasselaer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 24, 2021
Evaluating cut-off levels for progesterone, β human chorionic gonadotropin and β human chorionic gonadotropin ratio to exclude pregnancy viability in women with a pregnancy of unknown location: A prospective multicenter cohort studyShabnam Bobdiwala, Christopher Kyriacou, Evangelia Christodoulou, et al.
Fertility and Sterility|October 16, 2010
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcomeKurt Barnhart, Norah M van Mello, Tom Bourne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvementPatrick Neven, Olivier Brouckaert, Vanya Van Belle, et al.
BMJ Open|August 11, 2016
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancerSudha Sundar, Caroline Rick, Francis Dowling, et al.
Pageof 23